Vascugenix Prepares to Launch Speed-Torque Device: Designed to Improve the Process of Guidewire Manipulation in Cardiovascular Procedures

Tuesday, September 29, 2020

September 15, 2020

Vascugenix is a medical device company focused on developing innovative products to improve interventional cardiovascular procedures, is preparing to launch its first developed device, the Speed-Torque, in the U.S. market.

vascugenix Speed-TorqueVascugenix notes the Speed-Torque is specially designed to improve the process of guidewire manipulation in cardiovascular procedures. The patented design allows physicians to easily manipulate a guidewire with one hand, unlike traditional guidewire torque devices that require two hands to advance and reposition.

The Vascugenix team partnered with Gilero, a medical device design, development, and manufacturing company, to take this novel product idea from concept to commercialization.

“Vascugenix has worked closely with Gilero over the past nine months to develop and commercialize the Speed-Torque. Bringing a new device to the market during the COVID pandemic has been challenging, but Gilero and Vascugenix have worked closely together to make it happen,” says Martial Trigeaud, Chief Operating Officer for Vascugenix.

“Thanks to the dedication of Gilero, as well their Shenzhen-based injection molding partner Medacys, we were able to fully develop this device and bring it to market in a relatively short period of time,” adds Trigeaud. “The team at Vascugenix is excited to bring this product to market. The Speed-Torque will ultimately save physicians time, hospitals money, and improve patient safety.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here